These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 4561052)

  • 21. [Antibacterial effect of cephalexin monohydrate in urinary tract infections].
    Torres J; Guevara I; Hernandez H
    Prensa Med Mex; 1970; ():65-8. PubMed ID: 4931120
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents.
    Rohrich PJ; Ling GV; Ruby AL; Jang SS; Johnson DL
    J Am Vet Med Assoc; 1983 Oct; 183(8):863-7. PubMed ID: 6415021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of cephalexin monohydrate in female genitourinary infections. Report of 42 cases].
    Ricaud Rothiot L; Villalobos Roman M; Delgado Urdapilleta J
    Prensa Med Mex; 1970; ():40-1. PubMed ID: 4931115
    [No Abstract]   [Full Text] [Related]  

  • 24. [Nifurpipone in inflammatory diseases of the urinary tract].
    Laudi M; Ferrando V; Fontana G; Sesia G
    Minerva Urol; 1973; 25(3):149-57. PubMed ID: 4583091
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic and morphological observations derived from the use of cephalexin monohydrate].
    Escarzaga E; Luna M; Hill J; Gonzalez S; Gutierrez M; Horta C
    Prensa Med Mex; 1970; ():16-22. PubMed ID: 4931111
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical evaluation of cephalexin in urinary tract infection.
    Kawamura J
    Postgrad Med J; 1970 Oct; ():Suppl:28-30. PubMed ID: 4922708
    [No Abstract]   [Full Text] [Related]  

  • 27. [In vitro and in vivo antibacterial activity of cephapirin (author's transl)].
    Mitsuhashi S; Yaginuma S; Ono H; Kurashige S
    Jpn J Antibiot; 1974 Apr; 27(2):152-6. PubMed ID: 4211466
    [No Abstract]   [Full Text] [Related]  

  • 28. Oxolinic acid therapy for urinary tract infections in children.
    Shapera RM; Matsen JM
    Am J Dis Child; 1977 Jan; 131(1):34-7. PubMed ID: 319651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pattern of antimicrobial susceptibility in uropathogen isolates from children].
    Suárez VM; Suárez RC; Pérez BA; Alvarez FA; Castro SP; Rodríguez FS; Guerrero SM
    Rev Esp Quimioter; 2001 Mar; 14(1):63-8. PubMed ID: 11376352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary infections: results of treatment with composite long-acting sulphonamide (Dosulfin).
    Sutherland JW
    Br J Urol; 1965 Dec; 37(6):694-704. PubMed ID: 5322904
    [No Abstract]   [Full Text] [Related]  

  • 31. [Update on antibiotic therapy. 17) A combination of fosfomycin and cephalexin (cefemic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 May; 74(20):1217-22. PubMed ID: 6379514
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of urinary tract infections using pivampicillin].
    Schmidt-Mende M; Hofstetter A; Carl P; Keck W
    Munch Med Wochenschr; 1972 Sep; 114(39):1659-63. PubMed ID: 4263503
    [No Abstract]   [Full Text] [Related]  

  • 33. Brief exposure of bacteria to topical antibiotics.
    Scherr DD; Dodd TA
    Surg Gynecol Obstet; 1973 Jul; 137(1):87-90. PubMed ID: 4351660
    [No Abstract]   [Full Text] [Related]  

  • 34. [The antibacterial and chemotherapeutic activity of the Soviet produced antibiotic rifamitsina SV].
    Shorin VA; Shapovalova SP
    Antibiotiki; 1974 Jan; 19(1):3-6. PubMed ID: 4156904
    [No Abstract]   [Full Text] [Related]  

  • 35. [The role of ampicillin in antibiotic therapy with special reference to laboratory findings].
    Legler F
    Arzneimittelforschung; 1966 Jul; 16(7):814-8. PubMed ID: 4870009
    [No Abstract]   [Full Text] [Related]  

  • 36. Antimicrobial activity of 5-nitro-2-furaldehyde-N'-methyl-N-piperazino-acethydrazone, a new hydrosoluble nitrofuran derivative. Studies on in vivo chemotherapeutic activity.
    Degen L; Salvaterra M; Vella S; Pesatori M
    Chemotherapy; 1973; 18(2):85-90. PubMed ID: 4564391
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Septrin in the treatment of chronic pyelonephritis and certain other bacterial infections. Immediate effect of treatment after short-term administration of the drug].
    Droszcz W; Gietko G
    Pol Arch Med Wewn; 1970 Jun; 44(6):653-7. PubMed ID: 4915612
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and pharmacological evaluation of S-6436 (long acting preparation of cephalexin) in urinary tract infections (author's transl)].
    Takamoto H; Kamata H; Hirano M; Niijima T; Onoda T
    Kansenshogaku Zasshi; 1977 Jun; 51(6):343-52. PubMed ID: 411848
    [No Abstract]   [Full Text] [Related]  

  • 40. [Frequency and antibiotic susceptibility of bacteria responsible for urinary infections in private practice from 1986 to 1990. Results of 5398 samples].
    de Moüy D
    Pathol Biol (Paris); 1991 May; 39(5):495-9. PubMed ID: 1881681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.